This case-based panel will outline the multidisciplinary approach to patients with salivary cancer.  Perspective will be provided by experts in the field on topics such as extent of primary tumor surgery and management of cervical lymphatics, as well as indications for adjuvant radiation therapy

This session focuses on practical clinical challenges in the management of patients receiving radiopharmaceutical therapies (RPT).  Expert speakers discuss a broad range of common challenges related to radiation safety, renal and hematologic dysfunction, response assessment and decisions about di

There are many ongoing advances in patient safety in the context of radiation therapy delivery, clinical research on treatment options, and advanced techniques in radiotherapy delivery. Failure to stay informed leads to lower quality of care by practicing clinicians.

There is a great need for improvement in outcomes for HPV negative HNSCC patients. There are ongoing efforts to better understand the biology of HPV negative HNSCC, and reported and ongoing therapeutic clinical trials to try to improve outcomes in this patient population.

While most oncologists are familiar with the development, execution and reporting of interventional clinical trials that improve patient outcomes, there are unique challenges that must be considered when evaluating radioactive drugs.

The management of thyroid cancer is constantly evolving with new guidelines and new therapies available to support patients. Failure to stay informed leads to lower quality of care by practicing clinicians.

The treatment of early and advanced thyroid cancer is rapidly changing due to developments in targeted drug therapy and new surgical and minimally invasive approaches.  This session will familiarize the learner with the new targeted agents and their appropriate place in the treatment algorithms. 

This session will review the latest science in the field of radiopharmaceutical therapy.

This session will review the latest science in the field of head and neck cancer.

This session will review the latest science in the field of head and neck cancer.